A Novel mTORC1/2 Inhibitor (MTI-31) Inhibits Tumor Growth, Epithelial-Mesenchymal Transition, Metastases and Improves Cancer Immunity in Preclinical Lung Cancer Models

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-2548
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)


Related search